PRME logo

Prime Medicine, Inc. Common Stock


PRME: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.


Show PRME Financials

Consumer Interest
SEC Filings

Recent trades of PRME by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by PRME's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PRME in WallStreetBets Daily Discussion


Recent insights relating to PRME

CNBC Recommendations

Recent picks made for PRME stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PRME

Corporate Flights

Flights by private jets registered to PRME